The Quotes are Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.

U.K. Clinic aiming to benefit from the revolutionary efficiency in radiotherapy treatment when it starts using Elekta’s New Versa HD System

Wednesday, 10 April 2013
Elekta’s new Versa HD™ system will assist the Christie NHS Foundation Trust to harness new linear accelerator to improve therapy for patients with head-and-neck, lung and prostate cancers.

According to a press release from the Swedish medical appliance maker, Elekta, this will feature a revolutionary combination of speed and accuracy in helping the hospital cope with its task of curing illnesses when it starts applying the Elekta’s new Versa HD™ system.

Clinicians at The Christie NHS Foundation Trust (Withington, Manchester) will maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to new levels. Christie clinicians – who expect Versa HD to benefit a wide spectrum of patients suffering from head-and-neck, prostate and lung cancers – predict the system will be ready to begin treating patients by late spring, Elekta writes in a press release.

Unveiled by Elekta on March 1, the company says that the Versa HD is designed to be the most sophisticated, high-versatility treatment system. The system offers clinicians the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision. Treatment of the most challenging cases is addressed by ultra-conformal beam shaping working in concert with an innovative High Dose Rate mode – a potent combination that delivers both high precision and high treatment speeds.
More from the press release from the company can be accessed here
by Scancomark.com Team

We welcome your contribution. Did you find anything wrong with this article? Do you want to contribute to our news network? Do have a news tip or assist us with a correction